4//SEC Filing
RAUSCH CARL W 4
Accession 0001615774-18-001116
CIK 0001473579other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:30 PM ET
Size
16.4 KB
Accession
0001615774-18-001116
Insider Transaction Report
Form 4
RAUSCH CARL W
DirectorCEO
Transactions
- Purchase
Series A Preferred Stock
2017-08-14$0.10/sh+1,000,000$100,000→ 1,000,000 totalExercise: $0.10From: 2017-08-14→ Common Stock (1,000,000 underlying) - Purchase
Common Stock Purchase Warrants
2017-08-14$0.15/sh+2,000,000$300,000→ 2,000,000 totalExercise: $0.15From: 2017-08-14Exp: 2022-08-14→ Common Stock (2,000,000 underlying) - Purchase
Common Stock Purchase Warrants
2018-02-02$0.15/sh+2,000,000$300,000→ 2,000,000 totalExercise: $0.15From: 2018-02-02Exp: 2023-02-02→ Common Stock (2,000,000 underlying) - Purchase
Series A Preferred Stock
2018-02-02$0.10/sh+1,000,000$100,000→ 1,000,000 totalExercise: $0.10From: 2018-02-02→ Common Stock (1,000,000 underlying)
Holdings
- 6,000,000
Stock Options
Exercise: $0.20From: 2016-08-12Exp: 2021-08-12→ Common Stock (6,000,000 underlying) - 500,000
Stock Options
Exercise: $0.18From: 2015-03-25Exp: 2026-08-12→ Common Stock (500,000 underlying) - 1,500,000
Stock Options
Exercise: $0.10From: 2011-09-15Exp: 2026-08-12→ Common Stock (1,500,000 underlying)
Footnotes (2)
- [F1]The options vest in three equal tranches of 2,000,000 upon the Company the Company raising $1,000,000 in financing, the Company raising $5,000,000 in financing and the Company entering into a significant corporate alliance for substantial marketing and selling of the Company's product portfolio. The initial tranche is exercisable at $0.20 per share, the second tranche will be $0.40 per share and the third tranche will be $0.60 per share, which such vesting is subject to continued employment as an executive with the Company as of the vesting date. The expiration date is five years from the date of grant.
- [F2]On August 14, 2017 and February 2, 2018, World Technology East II Limited ("WTE") acquired 10,000 shares of Series A Preferred Stock and common stock purchase warrants to acquire 2,000,000 shares of common stock on each date. Mr. Rausch and Conroy Cheng each equally control WTE and share dispositive and voting control over such securities.
Documents
Issuer
Boston Therapeutics, Inc.
CIK 0001473579
Entity typeother
Related Parties
1- filerCIK 0001233999
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:30 PM ET
- Size
- 16.4 KB